| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |